Profile | GDS5420 / 214753_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 3737.25 | 96 |
GSM1296119 | B_lesional_pre-dose | 3425.88 | 95 |
GSM1296076 | C_lesional_pre-dose | 2391.81 | 90 |
GSM1296092 | D_lesional_pre-dose | 1583.41 | 85 |
GSM1296103 | E_lesional_pre-dose | 3462.77 | 95 |
GSM1296078 | F_lesional_pre-dose | 2502.09 | 91 |
GSM1296107 | G_lesional_pre-dose | 4124.12 | 96 |
GSM1296109 | H_lesional_pre-dose | 3477.35 | 95 |
GSM1296080 | I_lesional_pre-dose | 1454.88 | 84 |
GSM1296090 | J_lesional_pre-dose | 1550.53 | 85 |
GSM1296074 | K_lesional_pre-dose | 2068.31 | 88 |
GSM1296111 | L_lesional_pre-dose | 2828.79 | 93 |
GSM1296099 | M_lesional_pre-dose | 3001.92 | 94 |
GSM1296086 | O_lesional_pre-dose | 1833.32 | 87 |
GSM1296117 | P_lesional_pre-dose | 3309.93 | 95 |
GSM1296113 | Q_lesional_pre-dose | 3642.74 | 96 |
GSM1296096 | R_lesional_pre-dose | 2767.31 | 93 |
GSM1296105 | S_lesional_pre-dose | 2703.1 | 93 |
GSM1296098 | T_lesional_pre-dose | 3959.87 | 96 |
GSM1296101 | U_lesional_pre-dose | 4069.53 | 96 |
GSM1296121 | V_lesional_pre-dose | 3615.46 | 95 |
GSM1296088 | W_lesional_pre-dose | 2356.01 | 91 |
GSM1296082 | X_lesional_pre-dose | 2567.02 | 91 |
GSM1296115 | Y_lesional_pre-dose | 3118.35 | 94 |
GSM1296084 | Z_lesional_pre-dose | 2656.37 | 92 |
GSM1296072 | B_lesional_day8 | 4150.96 | 97 |
GSM1296069 | L_lesional_day8 | 3002 | 94 |
GSM1296071 | P_lesional_day8 | 3740.48 | 97 |
GSM1296070 | Y_lesional_day8 | 3453.71 | 96 |
GSM1296073 | V_lesional_day8 | 3193.34 | 94 |
GSM1296034 | A_lesional_day15 | 3727.12 | 96 |
GSM1296041 | G_lesional_day15 | 4151.01 | 96 |
GSM1296035 | R_lesional_day15 | 2671.2 | 93 |
GSM1296038 | U_lesional_day15 | 3938.7 | 96 |
GSM1296047 | B_lesional_day15 | 4301.77 | 97 |
GSM1296039 | E_lesional_day15 | 3380.14 | 94 |
GSM1296042 | H_lesional_day15 | 4334.83 | 97 |
GSM1296043 | L_lesional_day15 | 3914.99 | 97 |
GSM1296037 | M_lesional_day15 | 3876.76 | 95 |
GSM1296046 | P_lesional_day15 | 4090.73 | 97 |
GSM1296044 | Q_lesional_day15 | 4299.82 | 97 |
GSM1296045 | Y_lesional_day15 | 3542.64 | 96 |
GSM1296025 | C_lesional_day15 | 1736.88 | 87 |
GSM1296033 | D_lesional_day15 | 1866.3 | 88 |
GSM1296027 | I_lesional_day15 | 1692.45 | 86 |
GSM1296032 | J_lesional_day15 | 2023.1 | 90 |
GSM1296024 | K_lesional_day15 | 2137.93 | 90 |
GSM1296031 | W_lesional_day15 | 3057.32 | 94 |
GSM1296028 | X_lesional_day15 | 2465.95 | 92 |
GSM1296029 | Z_lesional_day15 | 2293.09 | 91 |
GSM1296026 | F_lesional_day15 | 1620.93 | 86 |
GSM1296030 | O_lesional_day15 | 1476 | 84 |
GSM1296040 | S_lesional_day15 | 3669.79 | 96 |
GSM1296036 | T_lesional_day15 | 3458.76 | 95 |
GSM1296048 | V_lesional_day15 | 3272.3 | 94 |
GSM1296059 | A_lesional_day43 | 2771.39 | 93 |
GSM1296066 | G_lesional_day43 | 4316.94 | 97 |
GSM1296060 | R_lesional_day43 | 2877.33 | 93 |
GSM1296063 | U_lesional_day43 | 2872.9 | 93 |
GSM1296064 | E_lesional_day43 | 3595.95 | 94 |
GSM1296067 | H_lesional_day43 | 4055 | 97 |
GSM1296062 | M_lesional_day43 | 2911.54 | 94 |
GSM1296068 | Q_lesional_day43 | 3938.72 | 97 |
GSM1296050 | C_lesional_day43 | 2760.81 | 93 |
GSM1296057 | D_lesional_day43 | 2141.36 | 90 |
GSM1296052 | I_lesional_day43 | 1700.79 | 87 |
GSM1296054 | J_lesional_day43 | 2567.04 | 93 |
GSM1296049 | K_lesional_day43 | 2712.35 | 93 |
GSM1296055 | W_lesional_day43 | 3229.1 | 95 |
GSM1296053 | X_lesional_day43 | 2674.85 | 93 |
GSM1296058 | Z_lesional_day43 | 2728.8 | 93 |
GSM1296051 | F_lesional_day43 | 2230.8 | 90 |
GSM1296056 | O_lesional_day43 | 2350.14 | 90 |
GSM1296065 | S_lesional_day43 | 2790.95 | 93 |
GSM1296061 | T_lesional_day43 | 2783.29 | 94 |
GSM1296095 | A_non-lesional_pre-dose | 4140.15 | 96 |
GSM1296120 | B_non-lesional_pre-dose | 4275.47 | 97 |
GSM1296077 | C_non-lesional_pre-dose | 1694.25 | 87 |
GSM1296093 | D_non-lesional_pre-dose | 1953.7 | 89 |
GSM1296104 | E_non-lesional_pre-dose | 4481.62 | 96 |
GSM1296079 | F_non-lesional_pre-dose | 2091.13 | 89 |
GSM1296108 | G_non-lesional_pre-dose | 5293.23 | 98 |
GSM1296110 | H_non-lesional_pre-dose | 4018.61 | 97 |
GSM1296081 | I_non-lesional_pre-dose | 842.14 | 76 |
GSM1296091 | J_non-lesional_pre-dose | 2009.8 | 89 |
GSM1296075 | K_non-lesional_pre-dose | 2579.85 | 92 |
GSM1296112 | L_non-lesional_pre-dose | 3904.37 | 97 |
GSM1296100 | M_non-lesional_pre-dose | 4079.53 | 96 |
GSM1296087 | O_non-lesional_pre-dose | 1641.54 | 86 |
GSM1296118 | P_non-lesional_pre-dose | 4166.58 | 97 |
GSM1296114 | Q_non-lesional_pre-dose | 5165.94 | 98 |
GSM1296097 | R_non-lesional_pre-dose | 3591.05 | 95 |
GSM1296106 | S_non-lesional_pre-dose | 4031.44 | 97 |
GSM1296102 | U_non-lesional_pre-dose | 4214.99 | 97 |
GSM1296122 | V_non-lesional_pre-dose | 3664.29 | 96 |
GSM1296089 | W_non-lesional_pre-dose | 2939.11 | 94 |
GSM1296083 | X_non-lesional_pre-dose | 1570.25 | 86 |
GSM1296116 | Y_non-lesional_pre-dose | 3853.21 | 97 |
GSM1296085 | Z_non-lesional_pre-dose | 2298.89 | 91 |